Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion type Assertion NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_head.
- NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend the potential options for therapeutic targeting of kinases in the treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_provenance.
- NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion evidence source_evidence_literature NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_provenance.
- NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion SIO_000772 14507635 NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_provenance.
- NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion wasDerivedFrom lhgdn-20090331 NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_provenance.
- NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_assertion wasGeneratedBy ECO_0000203 NP178684.RAF3iLqinsGw4eifgMLSNcfWZM81MVZzhr9yinlm4fkDk130_provenance.